Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension.

Mathew, R; Gloster, E S; Sundararajan, T; Thompson, C I; Zeballos, G A; Gewitz, M H

Mathew, R; Gloster, E S; Sundararajan, T; Thompson, C I; Zeballos, G A; Gewitz, M H.

Affiliation

Mathew R; Department of Pediatrics, New York Medical College, Valhalla 10595, USA.

J Appl Physiol (1985) ; 82(5): 1493-8, 1997 May.

Article in En | MEDLINE | ID: mdl-9134898

Subject(s)

Hypertension, Pulmonary/metabolism; Monocrotaline; Nitric Oxide/biosynthesis; Poisons; Animals; Arterioles/pathology; Blood Pressure; Hypertension, Pulmonary/chemically induced; Hypertrophy, Right Ventricular/metabolism; Injections, Subcutaneous; Male; Molsidomine/pharmacology; Nitrates/blood; Nitric Oxide/metabolism; Pulmonary Artery/pathology; Pulmonary Circulation/physiology; Rats; Rats, Sprague-Dawley; Vasodilator Agents/pharmacology; Weight Gain

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Poisons / Monocrotaline / Hypertension, Pulmonary / Nitric Oxide Limits: Animals Language: En Journal: J Appl Physiol (1985) Journal subject: FISIOLOGIA Year: 1997 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links